Sijing Li

1.1k total citations
40 papers, 797 citations indexed

About

Sijing Li is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Sijing Li has authored 40 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Sijing Li's work include Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (8 papers) and RNA modifications and cancer (6 papers). Sijing Li is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (8 papers) and RNA modifications and cancer (6 papers). Sijing Li collaborates with scholars based in China, Australia and France. Sijing Li's co-authors include Shengtao Yuan, Xiaohui Wei, Li Sun, Jinyong He, Xuemei Tian, Guoxian Pei, Feng Li, Lijun Lin, Yi Gao and Mingkui Shen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Carbohydrate Polymers and Biomacromolecules.

In The Last Decade

Sijing Li

35 papers receiving 783 citations

Peers

Sijing Li
Shuo Ni China
Huijuan Tang China
Yisheng Fang United States
Wentao Yang China
Lixin Xiang China
Wenhao Wang China
Hongbo Wu China
Junchao Xing China
Sheng Wen China
Yue Yang China
Shuo Ni China
Sijing Li
Citations per year, relative to Sijing Li Sijing Li (= 1×) peers Shuo Ni

Countries citing papers authored by Sijing Li

Since Specialization
Citations

This map shows the geographic impact of Sijing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sijing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sijing Li more than expected).

Fields of papers citing papers by Sijing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sijing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sijing Li. The network helps show where Sijing Li may publish in the future.

Co-authorship network of co-authors of Sijing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Sijing Li. A scholar is included among the top collaborators of Sijing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sijing Li. Sijing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Sijing, et al.. (2025). Financial investment and green development: How does financialization affect green total factor productivity?. Finance research letters. 78. 107258–107258. 5 indexed citations
2.
3.
Li, Sijing, Zamri Chik, Farid N. Faruqu, et al.. (2025). miRNAs and exosomes in psoriasis: coordinating cytoskeleton dynamics and extracellular matrix remodeling. Frontiers in Cell and Developmental Biology. 13. 1608902–1608902.
4.
5.
Lambertucci, Flavia, Sijing Li, Omar Motiño, et al.. (2024). Orthotopic Model of Hepatocellular Carcinoma in Mice. Methods in molecular biology. 2769. 1–13. 1 indexed citations
6.
Zhang, Shuai, Liwei Zhao, Mengfei Guo, et al.. (2023). Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses. Journal for ImmunoTherapy of Cancer. 11(7). e006785–e006785. 11 indexed citations
7.
Zhang, Junpeng, Lin Liu, Xuemei Wei, et al.. (2023). Pan-cancer characterization of ncRNA synergistic competition uncovers potential carcinogenic biomarkers. PLoS Computational Biology. 19(10). e1011308–e1011308. 4 indexed citations
8.
Liu, Yi, Sijing Li, & Yaling Liu. (2022). Machine Learning-Driven Multiobjective Optimization: An Opportunity of Microfluidic Platforms Applied in Cancer Research. Cells. 11(5). 905–905. 13 indexed citations
9.
Chen, Zhihan, et al.. (2022). Inhibition of Myocardial Cell Apoptosis Is Important Mechanism for Ginsenoside in the Limitation of Myocardial Ischemia/Reperfusion Injury. Frontiers in Pharmacology. 13. 806216–806216. 20 indexed citations
10.
Shen, Mingkui, Lulu Wang, Yi Gao, et al.. (2022). 3D bioprinting of in situ vascularized tissue engineered bone for repairing large segmental bone defects. Materials Today Bio. 16. 100382–100382. 59 indexed citations
11.
Shen, Fei, et al.. (2021). Network Pharmacology to Explore the Molecular Mechanisms of Prunella vulgaris for Treating Hashimoto’s Thyroiditis. Frontiers in Pharmacology. 12. 700896–700896. 28 indexed citations
12.
Zhang, Junpeng, Lin Liu, Taosheng Xu, et al.. (2021). Exploring cell-specific miRNA regulation with single-cell miRNA-mRNA co-sequencing data. BMC Bioinformatics. 22(1). 578–578. 14 indexed citations
13.
Zhang, Junpeng, Taosheng Xu, Lin Liu, et al.. (2020). LMSM: A modular approach for identifying lncRNA related miRNA sponge modules in breast cancer. PLoS Computational Biology. 16(4). e1007851–e1007851. 21 indexed citations
14.
Li, Sijing, Fenbo Ma, Xiangchao Pang, Bin Tang, & Lijun Lin. (2019). Synthesis of chondroitin sulfate magnesium for osteoarthritis treatment. Carbohydrate Polymers. 212. 387–394. 46 indexed citations
15.
Liu, Yan, Li Wang, Ying Liang, et al.. (2019). Prenatal diagnosis of fetal skeletal dysplasia using targeted next-generation sequencing: an analysis of 30 cases. Diagnostic Pathology. 14(1). 76–76. 36 indexed citations
16.
Li, Sijing, et al.. (2018). Tumor-associated Adipose Tissue Microenvironment Supports Tumor Progression. SHILAP Revista de lepidopterología.
17.
Li, Sijing, Xiaohui Wei, Jinyong He, et al.. (2018). Plasminogen activator inhibitor-1 in cancer research. Biomedicine & Pharmacotherapy. 105. 83–94. 130 indexed citations
18.
Li, Sijing, et al.. (2018). Prognostic value of ubiquitin-conjugating enzyme E2 S overexpression in hepatocellular carcinoma. International Journal of Biological Macromolecules. 119. 225–231. 15 indexed citations
19.
He, Jinyong, Xiaohui Wei, Sijing Li, et al.. (2018). DT-13 suppresses breast cancer metastasis by modulating PLOD2 in the adipocytes microenvironment. Phytomedicine. 59. 152778–152778. 13 indexed citations
20.
Li, Sijing. (2003). Discussion on Selection of Knowledge Management Model in Agriculture. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuo Ni Breakdown of academic impact, for papers by Huijuan Tang Breakdown of academic impact, for papers by Yisheng Fang Breakdown of academic impact, for papers by Wentao Yang Breakdown of academic impact, for papers by Lixin Xiang Breakdown of academic impact, for papers by Wenhao Wang Breakdown of academic impact, for papers by Hongbo Wu Breakdown of academic impact, for papers by Junchao Xing Breakdown of academic impact, for papers by Sheng Wen Breakdown of academic impact, for papers by Yue Yang
Rankless by CCL
2026